[
    [
        {
            "time": "2019-08-02",
            "original_text": "【医药】江琦、池陈森：2019年8月月报：不确定性中寻找确定性，创新与升级两大方向-20190802",
            "features": {
                "keywords": [
                    "不确定性",
                    "确定性",
                    "创新",
                    "升级"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药】江琦、池陈森：2019年8月月报：不确定性中寻找确定性，创新与升级两大方向-20190802",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "【广证恒生医药股权月报】科创板开盘全线飘红，高值耗材将进入“零差价”时代时代",
            "features": {
                "keywords": [
                    "科创板",
                    "全线飘红",
                    "高值耗材",
                    "零差价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "科创板"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【广证恒生医药股权月报】科创板开盘全线飘红，高值耗材将进入“零差价”时代时代",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "官方明确仿制药注册标准和药典标准关系！",
            "features": {
                "keywords": [
                    "仿制药",
                    "注册标准",
                    "药典标准"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "官方明确仿制药注册标准和药典标准关系！",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "政策边际改善，避风港优势再现||医药行业2019年8月份投资月报【兴证医药】",
            "features": {
                "keywords": [
                    "政策边际改善",
                    "避风港",
                    "医药行业"
                ],
                "sentiment_score": 0.8,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "政策边际改善，避风港优势再现||医药行业2019年8月份投资月报【兴证医药】",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "北上资金“深强沪弱” 增量资金将加速流入",
            "features": {
                "keywords": [
                    "北上资金",
                    "深强沪弱",
                    "增量资金"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "市场资金流向"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北上资金“深强沪弱” 增量资金将加速流入",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 7,
                "Time_Proximity": 4,
                "Headline_Structure": 6,
                "Source_Recency": 4
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "【医药丨周小刚】医药生物 8 月投资逻辑：积极配置医药消费 品、医疗器械和创新性标的",
            "features": {
                "keywords": [
                    "医药消费",
                    "医疗器械",
                    "创新性标的"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "【医药丨周小刚】医药生物 8 月投资逻辑：积极配置医药消费品、医疗器械和创新性标的",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "【天风医药】康泰生物：业绩短期下滑，13价肺炎疫苗等重磅品种值得期待 盈利能力下降",
            "features": {
                "keywords": [
                    "康泰生物",
                    "业绩短期下滑",
                    "13价肺炎疫苗",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【天风医药】康泰生物：业绩短期下滑，13价肺炎疫苗等重磅品种值得期待 盈利能力下降",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2019-08-02",
            "original_text": "【天风医药】凯莱英：半年报业绩高增长，定增助力业务版图扩张",
            "features": {
                "keywords": [
                    "凯莱英",
                    "半年报",
                    "业绩高增长",
                    "定增",
                    "业务版图扩张"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】凯莱英：半年报业绩高增长，定增助力业务版图扩张",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 3,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        }
    ]
]